Does CBD Convert to THC in the Stomach?

For years, one question has continued to circulate in the cannabis and hemp industries, as researchers have wondered if CBD can turn into THC after you swallow it. The idea sounds concerning and even fictional. However, some laboratory experiments have indeed reported that CBD can produce THC and other cannabinoids when exposed to simulated gastric conditions.

However, an important part of the story often gets lost in the reporting: what happens in a laboratory flask is not necessarily what happens inside the human digestive system. An emerging study¹ published in the European Journal of Pharmaceutical Sciences revisits decades of conflicting research surrounding gastric CBD to THC conversion. Its conclusion offers a much more nuanced picture than ever before. Let’s dive into the research and uncover if CBD actually converts to THC in your stomach.

Why CBD Could Convert to THC

Chemically, CBD can undergo acid-catalyzed reactions that rearrange its molecular structure and produce THC-related compounds. That much is supported by laboratory chemistry. However, the controversy concerns whether this reaction happens to a meaningful extent during normal human digestion.

According to the 2026 review, CBD to THC conversion appears to require an unusually specific combination of conditions involving strong acidity, direct accessibility of CBD to that acidic environment, and stabilization of a protonated carbocation intermediate involved in the ring-closing reaction that can produce THC.

That combination is critical, as simply exposing CBD to an acidic environment does not establish that clinically meaningful amounts of THC will be produced. The CBD must be sufficiently accessible to the acid, while the chemical intermediate involved in the reaction must also be stabilized long enough for the conversion to proceed. This helps explain why different laboratory experiments have produced very different results.

What Earlier CBD Research Found

One of the studies that fueled concerns about CBD becoming THC was published in 2016. Researchers exposed CBD to simulated gastric fluid containing 1% sodium dodecyl sulfate (SDS), a surfactant used to improve CBD’s poor water solubility. Under those laboratory conditions, researchers reported substantial CBD degradation and detected both Delta 9 THC and Delta 8 THC. The findings attracted considerable attention because they raised the possibility that orally consumed CBD could generate psychoactive cannabinoids in the stomach.

However, there was a major caveat. The experimental system was not simply human stomach fluid. The simulated gastric fluid used in the study contained SDS specifically to keep CBD dispersed. That formulation choice matters because surfactants can alter how a poorly water-soluble molecule behaves in an acidic environment.

Other researchers subsequently questioned whether the experimental conditions accurately represented the physiological environment inside the human stomach. This is where the distinction between laboratory possibility and human biology becomes particularly important.

What Happens When Humans Take CBD?

If CBD were routinely converting into meaningful amounts of THC inside the stomach, researchers would expect evidence of that conversion to appear in human pharmacokinetic studies. So far, that evidence has not emerged in a convincing way.

In a controlled human pharmacokinetic study involving 120 healthy adults, researchers administered 300 mg of oral CBD to participants under both fasting and fed conditions. THC was not detected in plasma, and participants did not demonstrate psychotomimetic effects consistent with THC exposure. This finding is important because it directly examines what happens after humans actually consume CBD rather than relying solely on simulated gastric fluid.

Taken together with other human evidence, the findings do not demonstrate significant THC formation or THC-like intoxicating effects after consuming THC-free CBD. It also does not prove that absolutely no individual CBD molecule could ever undergo a chemical transformation during digestion. Biology rarely provides such absolute answers. Instead, the available evidence indicates that the substantial CBD to THC conversion observed under certain laboratory conditions has not been shown to occur to a clinically meaningful degree in humans.

Why CBD Formulation Still Matters

There is, however, an intriguing consideration that should be taken. CBD is notoriously difficult to dissolve in water. Because poor solubility can limit oral absorption, researchers and product developers have explored technologies that make CBD more readily dispersible or “water soluble.” These include emulsions, micellar systems, and other solubility-enhancing formulations.

And this is where the current research raises an important question. If a formulation changes how accessible CBD is to stomach acid, could it also change CBD’s chemical behavior under acidic conditions? Unfortunately, the answer is not yet fully known. Additional investigation of micellar CBD formulations containing anionic surfactants under fasted and acidic gastric conditions will be needed, as these formulations could potentially create some of the conditions researchers believe are necessary for conversion.

The Human Stomach Is Not a Test Tube

One of the most important points in this debate is that simulated gastric fluid is just that, simulated. The human stomach is a dynamic biological environment. Its acidity can change, its contents are constantly moving, food can alter gastric conditions, and material does not necessarily remain exposed to exactly the same chemical environment for extended periods.

Researchers have also identified important differences between laboratory gastric models and real digestion, including pH, gastric retention time, composition, and physiological processes. Those differences can dramatically influence whether a chemical reaction observed in vitro is relevant in vivo. That is why detecting THC in a laboratory experiment should not automatically be interpreted as evidence that a person who takes CBD will produce enough THC to become intoxicated.

So, Does CBD Become THC?

Based on the evidence available today, there is no convincing evidence that conventional oral CBD routinely converts into clinically significant amounts of THC in the human stomach. The concern originated largely from laboratory experiments using highly specific conditions that may not accurately reproduce human digestion.

While there was one particularly influential experiment that used CBD in simulated gastric fluid containing SDS and demonstrated that CBD could produce THC-related compounds under those conditions, the subsequent research and human studies have failed to establish that the same process occurs to a meaningful degree in people. The newest review therefore characterizes CBD-to-THC conversion in humans as a speculative scenario, rather than an established physiological phenomenon.

What Researchers Need to Study Next

The next phase of research should focus less on asking whether CBD can become THC and more on determining whether specific modern formulations can meaningfully alter that chemistry under conditions that better approximate human digestion. This means testing advanced formulations, including micellar CBD systems containing appropriate anionic surfactants, under carefully controlled conditions. Most importantly, researchers need to determine whether any conversion observed in these models translates into measurable THC exposure or physiological effects in humans.

For now, the evidence supports a cautious conclusion that while CBD may have a complicated relationship with stomach acid in a test tube, there is still no solid scientific basis for claiming that taking CBD routinely turns it into an intoxicating THC dose inside the body. As CBD formulations continue to evolve, however, that remains a scientific question worth investigating, but not a proven reason for alarm.

References:

^{1. Jens B. Simonsen , Heidi Ziegler Bruun , Julia Hoeng , Sanne Skov Jensen , Revisiting the literature on gastric CBD-to-THC conversion: contex tualizing conflicting evidence, European Journal of Pharmaceutical Sciences (2026), doi: https://doi.org/10.1016/j.ejps.2026.107632}